Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Intellect and MRC Technology achieve milestone in Alzheimer's therapeutic antibody program

July 1, 2008

Neuren to finish phase III Glypromate trial 6 months ahead of schedule

July 1, 2008

Duloxetine effective in reducing osteoarthritis knee pain

July 1, 2008

Novel agents for psychiatric disorders reported in recent patent literature

June 30, 2008

PN-277 shows benefit in experimental Parkinson's disease

June 30, 2008

ACR-325 advances into phase II PoC studies in PD, bipolar disorder

June 30, 2008

Hisamitsu files for approval in Japan of HFT-290 in cancer pain

June 30, 2008

CHMP recommends approval of Abstral for breakthrough cancer pain

June 30, 2008

CHMP issues positive opinion for UCB's Vimpat in epilepsy

June 30, 2008

CHMP issues positive opinion for Cymbalta in generalized anxiety disorder

June 30, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...